Protalix BioTherapeutics, Inc. Logo

Protalix BioTherapeutics, Inc.

Develops therapeutic proteins for rare diseases using a plant cell-based platform.

PLX | US

Overview

Corporate Details

ISIN(s):
US74365A3095
LEI:
Country:
United States of America
Address:
2 UNIVERSITY PLAZA, 7601 HACKENSACK

Description

Protalix BioTherapeutics, Inc. is a biopharmaceutical company that develops, produces, and commercializes recombinant therapeutic proteins. The company's unique selling point is its proprietary ProCellEx® platform, a plant cell-based protein expression system used to manufacture complex proteins. This technology supports the development of treatments for rare and orphan diseases. Protalix has successfully brought enzyme replacement therapies to market and maintains a pipeline of product candidates targeting conditions with high unmet medical needs. The company's capabilities cover the entire process from protein candidate selection and genetic engineering of plant cells through preclinical and clinical development to commercial-scale production and marketing.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-04-30 18:30
DEF 14A
English 1.4 MB
2025-04-30 14:36 English 57.9 KB
2025-04-28 19:00
FORM S-3
English 325.1 KB
2025-04-23 18:30
8-K
English 70.0 KB
2025-03-17 18:19
8-K
English 115.4 KB
2025-03-17 17:33
424B5
English 219.8 KB
2025-03-17 08:18
10-K
English 3.6 MB
2025-03-17 07:55
8-K
English 133.7 KB
2024-12-31 17:30
8-K
English 174.3 KB
2024-12-23 08:01
8-K
English 103.2 KB
2024-11-14 08:03
10-Q
English 1.6 MB
2024-11-14 07:57
8-K
English 133.0 KB
2024-11-05 18:00 English 7.7 KB
2024-10-25 18:23 English 17.7 KB
2024-10-25 10:27
8-K
English 95.8 KB

Automate Your Workflow. Get a real-time feed of all Protalix BioTherapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Protalix BioTherapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Protalix BioTherapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.